Michael Bruckman/LinkedIn
Dec 17, 2025, 05:54
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn:
”Fantastic to see platelet-inspired nanoparticles gaining attention!
This work with Case Western Reserve University and Haima Therapeutics demonstrates how targeted drug delivery at sites of injury can dramatically improve outcomes; in this case, enhancing implanted electrode performance.
Excited about the broad potential of this platform, from neuroscience to trauma care and beyond.”
Read the full article here.
Article: Platelet-inspired nanoparticle delivers drugs directly where they are needed
Authors: Julia Rock-Torcivia
Stay updated on all scientific advances with Hemostasis Today.
-
May 17, 2026, 06:26The Long-Term Organ-Specific Complications of Nonextremity Thrombosis in Children – JTH
-
May 17, 2026, 04:41Rob Maloney: Hemophilia of Georgia Exists to Build the Support System Around People Living with Bleeding Disorders
-
May 17, 2026, 04:36Purusotham Chippala: Hemineglect Is One of The Most Misunderstood Conditions After Stroke
-
May 17, 2026, 04:27Andreas Calatzis: The Limitations of Monitoring Unfractionated Heparin During ECMO
-
May 17, 2026, 04:06Mohamed F Doheim: Honored to Defend My PhD on Personalized Decision-Making in Acute Ischemic Stroke
-
May 17, 2026, 04:00Sandeep De: Long COVID and the Microvascular Obstruction with Amyloid-Like Microclots
-
May 17, 2026, 00:05Karin Stanboulian: Professional Networking and Innovation at CRACONNECT 2026
-
May 16, 2026, 23:12Lisa Murphy: Farewelling Linda Kristjanson – A Lifelong Champion and Supporter of Stroke Foundation
-
May 16, 2026, 19:58Tobias Lahmer: Is Platelet Count the Key Predictor for Intracerebral Hemorrhage in ACLF?